Anticorps monoclonaux
Planifiez un 2-8 C route around no-freeze protection, support de carton, controlled PCM contact, and logger placement at both warm and cold risk points.
Biopharmaceuticals Cold Chain Packaging Solutions
Biopharmaceutical shipments should be planned from the product form first: refrigerated antibodies, cryogenic cell therapies, and frozen gene therapy vectors do not fail in the same way. Tempk helps map the temperature range, shipper structure, coolant or dry shipper choice, monitoring position, and receiving checks before route validation.
Start with the biologic form
A single medical parcel setup can be too warm for one product and too cold for another. The useful first step is to separate the payload by risk: freeze-sensitive refrigerated biologics, living cell products that may require vapor-phase liquid nitrogen, and vectors that often need frozen or ultra-low frozen control.
Cell Therapy Products
Use the product SOP to decide whether a vapor-phase liquid nitrogen dry shipper is required, then protect chain of identity, orientation, and hold-time margin.
Gene Therapy Vectors
Choose dry ice or a dry shipper only after the labeled storage range is clear. Empêcher le dégel, refrection, vial pressure, frost damage, and paperwork loss.
Practical packout choices by route
| Product route | Intention de température | Packaging setup | Coolant or dry shipper planning | Réception du chèque |
|---|---|---|---|---|
| Anticorps monoclonaux, sample or commercial 2-8 C lane | Hold the labeled refrigerated range and prevent freezing at the coolant face. | Expéditeur isolé qualifié, payload carton support, foam or corrugated divider, contrôle de la condensation, and a logger near the likely warm and cold positions. | Use conditioned 2-8 C PCM or refrigerated gel packs behind a barrier. For a small 3-8 L expéditeur, many trials start around 0.8-2.5 kg coolant, then adjust by season and lane. | Courbe de température, état du carton, no frozen coolant marks, lisibilité de l'étiquette, et heure de réception. |
| Produits de thérapie cellulaire, cryogenic hospital or manufacturing route | Follow the product SOP. When cryogenic control is required, keep the payload in a validated vapor-phase liquid nitrogen dry shipper. | Pre-charged dry shipper, cassette or canister fit check, confinement secondaire, sceau d'inviolabilité, orientation control, chain-of-identity and chain-of-custody paperwork. | Plan by validated hold time, not ice-pack mass. Route time should leave reserve margin for pickup, retard de vol, douane, et recevoir la préparation. | Dry shipper condition, custody record, orientation or shock indicator, remaining hold-time record, and receiver signoff. |
| Vecteurs de thérapie génique, frozen or ultra-low frozen lane | Use the labeled range, often frozen or ultra-low frozen. Avoid thaw and refreeze during packout or handoff. | Dry ice shipper or dry shipper as required, vial rack support, séparation par glace carbonique, vented outer package, document sleeve protected from frost and moisture. | If dry ice is allowed, small parcels often begin trials around 3-7 kg for 0-24 h lanes and 8-15 kg for 24-48 voies h. Use a validated dry shipper when the product requires LN2 conditions. | Logger record, remaining dry ice or shipper hold margin, no vial movement, no frost-damaged documents, and immediate freezer transfer. |
These ranges are planning examples for packaging discussion. Final packout acceptance must follow the product label, sponsor SOP, qualification de voie, règles du transporteur, et les exigences réglementaires locales.
Temperature validation curve
Use the curve to compare refrigerated, cryogénique, and frozen behavior before you repeat the route. A useful review combines the logger curve with payload condition, délai de prise en charge, transfer steps, et recevoir des notes.
More biologic routes
Recombinant proteins and enzyme replacement therapies also need product-specific handling, especially for freeze sensitivity, aggregation control, vial support, et des enregistrements.
Recombinant Protein Therapeutics Cold Chain Packaging Guide
2-8 C packaging with no-freeze protection, aggregation-aware handling, support de carton, surveillance, and receiving records.
Enzyme Replacement Therapies Cold Chain Packaging Guide
Refrigerated therapeutic packaging with vial protection, no direct frozen coolant contact, transfert contrôlé, et contrôles d'itinéraire.
Useful Tempk tools and related solution pages
Use these pages to compare coolant behavior, risque d'itinéraire, shipper structure, and nearby medical cold chain cases before requesting a sample or lane test.
Liquide de refroidissement & Référence PCMVérificateur de risque d'itinéraireCalculateur de banquiseCalculateur de glace carboniqueInsulation Material ReferenceOutils pour la chaîne du froidPack réfrigérant en gelBoîte PPEBoîte en carton isolantMédicamentsVaccinsProduits sanguinsÉchantillons cliniquesAll cold chain solutions
Need a biopharmaceutical packout reviewed?
Partager le type de produit, labeled temperature range, Taille de la charge utile, durée de l'itinéraire, températures des voies, handoff limits, monitoring requirement, et processus de réception. Tempk can help compare the insulated shipper, PCM, glace carbonique, dry shipper, support insert, et plan de validation.